Study Objective: The COVID-19 pandemic put an immense strain on emergency departments (ED) throughout the country. Many patients required hospitalization, while others required symptomatic care and testing. We established a novel triage and treatment process, using a combination of telemedicine and a tent site adjacent to the ED, that provided safer and more efficient patient care.Methods: We conducted a retrospective study of patients with suspected COVID-19 evaluated at a suburban, academic medical center in Long Island, New York. Patients who presented to the ED with symptoms of COVID-19 during a 30-day timeframe between the hours of 11 am to 7 pm were triaged by vital signs and a questionnaire at the main ED entrance. If appropriate, patients were then directed to our tent site. Our primary outcome was 30-day return visits for acute medical concerns related to COVID-19.Results: We assessed 693 patients. 505 patients (73%) tested positive for COVID-19. The mean age was 41.6 years old. In regards to 30-day revisits, a total of 74 patients (10.1%) returned to the ED, and 38 (5.5%) of these were related to COVID-19. Of this group, 11 patients (1.6%) were admitted to the hospital, including one ICU admission. There was one death in the 30-day revisit group (COVID-related complications).Conclusion: Our novel triage and evaluation model provided a safe environment for testing and treating patients during the first wave of the COVID-19 pandemic. This information can help emergency departments provide alternative treatment models to care for patients during future surge scenarios. Outcome Variable Patients Per Day (mean, range) 21.7 (0 -42) Tent Length of Stay (mean minutes, range) 43 (13 -349)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.